These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19767632)

  • 21. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
    Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
    Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
    Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
    J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
    Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
    Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
    Opatrna S; Lysak D; Trefil L; Parker C; Topley N
    Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange.
    Davies SJ; Garcia Lopez E; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimburger O; Simonsen O; Davenport A; Lindholm B; Tranaeus A; Divino Filho JC
    Nephrol Dial Transplant; 2008 Sep; 23(9):2982-8. PubMed ID: 18456678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
    Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
    Maurer O; Saxenhofer H; Jaeger P; Casez JP; Descoeudres C; Horber FF
    Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients.
    Law S; Davenport A
    Br J Nutr; 2020 Jun; 123(11):1269-1276. PubMed ID: 31992383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD.
    Bouchi R; Babazono T; Inoue A; Tanaka M; Tanaka N; Hase M; Ishii A; Iwamoto Y
    Perit Dial Int; 2006; 26(5):604-7. PubMed ID: 16973520
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.
    Orihuela O; de Jesús Ventura M; Ávila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Alcántara G; Lindholm B; García-López E; Villanueva C; Paniagua R
    Perit Dial Int; 2014; 34(1):57-63. PubMed ID: 24525598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.
    Cho KH; Do JY; Park JW; Yoon KW; Kim YL
    Perit Dial Int; 2013; 33(4):382-90. PubMed ID: 23284074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.